Gastroenterology Research of America, LLC

San Antonio, Texas 78229

2 studies enrolling now · 6 studies all time

What they study most

Colitis, Ulcerative, Crohn Disease, Crohn's Disease, Moderately to Severely Active Crohns Disease, Ulcerative Colitis

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• VE202 in Patients With Mild-to-Moderate Ulcerative Colitis — Stopped early
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease — Completed